New approaches to HIV vaccine development

Current Opinion in Immunology

Volumn 35, Issue , 2015, Pages 39-47

  Haynes, Barton F ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ACTIVE IMMUNIZATION; ANTIBODY PRODUCTION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; DRUG RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; NONHUMAN; REVIEW; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; ANIMAL; CYTOTOXICITY; HIV INFECTIONS; IMMUNE EVASION; IMMUNOLOGY; VIROLOGY;

AIDS VACCINES; ANIMALS; ANTIBODIES, NEUTRALIZING; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HIV INFECTIONS; HUMANS; IMMUNE EVASION;

EID: 84930948323     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.05.007     Document Type: Review

References (67)

1. McMichael A.J., Borrow P., Tomaras G.D., Goonetilleke N., Haynes B.F. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2010, 10:11-23. PubMed PMID: 20010788; PubMed Central PMCID: PMC3119211. 10.1038/nri2674.
2. Goonetilleke N., Liu M.K., Salazar-Gonzalez J.F., Ferrari G., Giorgi E., Ganusov V.V., Keele B.F., Learn G.H., Turnbull E.L., Salazar M.G., Weinhold K.J., Moore S.B.C.C.C., Letvin N., Haynes B.F., Cohen M.S., Hraber P., Bhattacharya T., Borrow P., Perelson A.S., Hahn B.H., Shaw G.M., Korber B.T., McMichael A.J. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009, 206:1253-1272. PubMed PMID: 19487423; PubMed Central PMCID: PMC2715063. 10.1084/jem.20090365.
3. Walker B.D., Yu X.G. Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol 2013, 13:487-498. PubMed PMID: 23797064. 10.1038/nri3478.
4. Hansen S.G., Sacha J.B., Hughes C.M., Ford J.C., Burwitz B.J., Scholz I., Gilbride R.M., Lewis M.S., Gilliam A.N., Ventura A.B., Malouli D., Xu G., Richards R., Whizin N., Reed J.S., Hammond K.B., Fischer M., Turner J.M., Legasse A.W., Axthelm M.K., Edlefsen P.T., Nelson J.A., Lifson J.D., Fruh K., Picker L.J. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 2013, 340:1237874. PubMed PMID: 23704576; PubMed Central PMCID: PMC3816976. 10.1126/science.1237874.
5. Hansen S.G., Piatak M., Ventura A.B., Hughes C.M., Gilbride R.M., Ford J.C., Oswald K., Shoemaker R., Li Y., Lewis M.S., Gilliam A.N., Xu G., Whizin N., Burwitz B.J., Planer S.L., Turner J.M., Legasse A.W., Axthelm M.K., Nelson J.A., Fruh K., Sacha J.B., Estes J.D., Keele B.F., Edlefsen P.T., Lifson J.D., Picker L.J. Immune clearance of highly pathogenic SIV infection. Nature 2013, 502:100-104. PubMed PMID: 24025770; PubMed Central PMCID: PMC3849456. 10.1038/nature12519.
6. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., Benenson M., Gurunathan S., Tartaglia J., McNeil J.G., Francis D.P., Stablein D., Birx D.L., Chunsuttiwat S., Khamboonruang C., Thongcharoen P., Robb M.L., Michael N.L., Kunasol P., Kim J.H., Investigators M.-T. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361:2209-2220. PubMed PMID: 19843557. 10.1056/NEJMoa0908492.
7. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pazner S., Tomaras G.D., Alam S.M., Evans D.T., Montefiori D.C., Karnasuta C., Sutthent R., Liao H.X., DeVico A.L., Lewis G.K., Williams C., Pinter A., Fong Y., Janes H., DeCamp A., Huang Y., Rao M., Billings E., Karasavvas N., Robb M.L., Ngauy V., de Souza M.S., Paris R., Ferrari G., Bailer R.T., Soderberg K.A., Andrews C., Berman P.W., Frahm N., De Rosa S.C., Alpert M.D., Yates N.L., Shen X., Koup R.A., Pitisuttithum P., Kaewkungwal J., Nitayaphan S., Rerks-Ngarm S., Michael N.L., Kim J.H. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012, 366:1275-1286. PubMed PMID: 22475592; PubMed Central PMCID: PMC3371689. 10.1056/NEJMoa1113425.
8. Rolland M., Edlefsen P.T., Larsen B.B., Tovanabutra S., Sanders-Buell E., Hertz T., deCamp A.C., Carrico C., Menis S., Magaret C.A., Ahmed H., Juraska M., Chen L., Konopa P., Nariya S., Stoddard J.N., Wong K., Zhao H., Deng W., Maust B.S., Bose M., Howell S., Bates A., Lazzaro M., O'Sullivan A., Lei E., Bradfield A., Ibitamuno G., Assawadarachai V., O'Connell R.J., deSouza M.S., Nitayaphan S., Rerks-Ngarm S., Robb M.L., McLellan J.S., Georgiev I., Kwong P.D., Carlson J.M., Michael N.L., Schief W.R., Gilbert P.B., Mullins J.I., Kim J.H. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 2012, 490:417-420. PubMed PMID: 22960785; PubMed Central PMCID: PMC3551291. 10.1038/nature11519.
9. Liao H.X., Bonsignori M., Alam S.M., McLellan J.S., Tomaras G.D., Moody M.A., Kozink D.M., Hwang K.K., Chen X., Tsao C.Y., Liu P., Lu X., Parks R.J., Montefiori D.C., Ferrari G., Pollara J., Rao M., Peachman K.K., Santra S., Letvin N.L., Karasavvas N., Yang Z.Y., Dai K., Pancera M., Gorman J., Wiehe K., Nicely N.I., Rerks-Ngarm S., Nitayaphan S., Kaewkungwal J., Pitisuttithum P., Tartaglia J., Sinangil F., Kim J.H., Michael N.L., Kepler T.B., Kwong P.D., Mascola J.R., Nabel G.J., Pinter A., Zolla-Pazner S., Haynes B.F. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 2013, 38:176-186. PubMed PMID: 23313589; PubMed Central PMCID: PMC3569735. 10.1016/j.immuni.2012.11.011.
10. Bonsignori M., Pollara J., Moody M.A., Alpert M.D., Chen X., Hwang K.K., Gilbert P.B., Huang Y., Gurley T.C., Kozink D.M., Marshall D.J., Whitesides J.F., Tsao C.Y., Kaewkungwal J., Nitayaphan S., Pitisuttithum P., Rerks-Ngarm S., Kim J.H., Michael N.L., Tomaras G.D., Montefiori D.C., Lewis G.K., DeVico A., Evans D.T., Ferrari G., Liao H.X., Haynes B.F. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol 2012, 86:11521-11532. PubMed PMID: 22896626; PubMed Central PMCID: PMC3486290. 10.1128/JVI.01023-12.
11. Tomaras G.D., Ferrari G., Shen X., Alam S.M., Liao H.X., Pollara J., Bonsignori M., Moody M.A., Fong Y., Chen X., Poling B., Nicholson C.O., Zhang R., Lu X., Parks R., Kaewkungwal J., Nitayaphan S., Pitisuttithum P., Rerks-Ngarm S., Gilbert P.B., Kim J.H., Michael N.L., Montefiori D.C., Haynes B.F. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proc Natl Acad Sci U S A 2013, 110:9019-9024. PubMed PMID: 23661056; PubMed Central PMCID: PMC3670311. 10.1073/pnas.1301456110.
12. Pollara J., Bonsignori M., Moody M.A., Liu P., Alam S.M., Hwang K.K., Gurley T.C., Kozink D.M., Armand L.C., Marshall D.J., Whitesides J.F., Kaewkungwal J., Nitayaphan S., Pitisuttithum P., Rerks-Ngarm S., Robb M.L., O'Connell R.J., Kim J.H., Michael N.L., Montefiori D.C., Tomaras G.D., Liao H.X., Haynes B.F., Ferrari G. HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities. J Virol 2014, 88:7715-7726. PubMed PMID: 24807721; PubMed Central PMCID: PMC4097802. 10.1128/JVI.00156-14.
13. Hraber P., Seaman M.S., Bailer R.T., Mascola J.R., Montefiori D.C., Korber B.T. Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection. AIDS 2014, 28:163-169. PubMed PMID: 24361678; PubMed Central PMCID: PMC4042313. 10.1097/QAD.0000000000000106.
14. Gray E.S., Madiga M.C., Hermanus T., Moore P.L., Wibmer C.K., Tumba N.L., Werner L., Mlisana K., Sibeko S., Williamson C., Abdool Karim S.S., Morris L., Team C.S. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. J Virol 2011, 85:4828-4840. PubMed PMID: 21389135; PubMed Central PMCID: PMC3126191. 10.1128/JVI.00198-11.
15. Tomaras G.D., Binley J.M., Gray E.S., Crooks E.T., Osawa K., Moore P.L., Tumba N., Tong T., Shen X., Yates N.L., Decker J., Wibmer C.K., Gao F., Alam S.M., Easterbrook P., Abdool Karim S., Kamanga G., Crump J.A., Cohen M., Shaw G.M., Mascola J.R., Haynes B.F., Montefiori D.C., Morris L. Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. J Virol 2011, 85:11502-11519. PubMed PMID: 21849452; PubMed Central PMCID: PMC3194956. 10.1128/JVI.05363-11.
16. Mascola J.R., Haynes B.F. HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol Rev 2013, 254:225-244. PubMed PMID: 23772623; PubMed Central PMCID: PMC3738265. 10.1111/imr.12075.
17. Burton D.R., Mascola J.R. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol 2015, 16.
18. Wu X., Zhang Z., Schramm C.A., Joyce M.G., Do Kwon Y., Zhou T., Sheng Z., Zhang B., O'Dell S., McKee K., Georgiev I.S., Chuang G.Y., Longo N.S., Lynch R.M., Saunders K.O., Soto C., Srivatsan S., Yang Y., Bailer R.T., Louder M.K., Program N.C.S., Mullikin J.C., Connors M., Kwong P.D., Mascola J.R., Shapiro L. Maturation and diversity of the VRC01-antibody lineage over 15 years of chronic HIV-1 infection. Cell 2015, 161:470-485. PubMed PMID: 25865483. 10.1016/j.cell.2015.03.004.
19. Morris L., Chen X., Alam M., Tomaras G., Zhang R., Marshall D.J., Chen B., Parks R., Foulger A., Jaeger F., Donathan M., Bilska M., Gray E.S., Abdool Karim S.S., Kepler T.B., Whitesides J., Montefiori D., Moody M.A., Liao H.X., Haynes B.F. Isolation of a human anti-HIV gp41 membrane proximal region neuralizing antibody by antigen-specific single B cell sorting. PLoS One 2011, 6:e23532. PMID: 21980336.
20. Stiegler G., Kunert R., Purtscher M., Wolbank S., Voglauer R., Steindl F., Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus Tupe 1. AIDS Res Hum Retroviruses 2001, 17:1757-1765.
21. Yang G., Holl T.M., Liu Y., Li Y., Lu X., Nicely N.I., Kepler T.B., Alam S.M., Liao H.X., Cain D.W., Spicer L., VandeBerg J.L., Haynes B.F., Kelsoe G. Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med 2013, 210:241-256. PubMed PMID: 23359068; PubMed Central PMCID: PMC 3570098. 10.1084/jem.20121977.
22. Liu M., Yang G., Wiehe K., Nicely N.I., Vandergrift N.A., Rountree W., Bonsignori M., Alam S.M., Gao J., Haynes B.F., Kelsoe G. Polyreactivity and autoreactivity among HIV-1 antibodies. J Virol 2015, 89:784-798. PubMed PMID: 25355869; PubMed Central PMCID: PMC 4301171. 10.1128/JVI.02378-14.
23. Haynes B.F., Fleming J., St Clair E.W., Katinger H., Stiegler G., Kunert R., Robinson J., Scearce R.M., Plonk K., Staats H.F., Ortel T.L., Liao H.X., Alam S.M. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005, 308:1906-1908. PubMed PMID: 15860590. 10.1126/science.1111781.
24. Verkoczy L., Kelsoe G., Moody M.A., Haynes B.F. Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Curr Opin Immunol 2011, 23:383-390. PubMed PMID: 21524897; PubMed Central PMCID: PMC3139952. 10.1016/j.coi.2011.04.003.
25. Chen Y., Zhang J., Hwang K.K., Bouton-Verville H., Xia S.M., Newman A., Ouyang Y.B., Haynes B.F., Verkoczy L. Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10,. J Immunol 2013, 191:1260-1275. PubMed PMID: 23825311; PubMed Central PMCID: PMC3725147. 10.4049/jimmunol.1300770.
26. Verkoczy L., Chen Y., Zhang J., Bouton-Verville H., Newman A., Lockwood B., Scearce R.M., Montefiori D.C., Dennison S.M., Xia S.M., Hwang K.K., Liao H.X., Alam S.M., Haynes B.F. Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J Immunol 2013, 191:2538-2550. PubMed PMID: 23918977; PubMed Central PMCID: PMC3870053. 10.4049/jimmunol.1300971.
27. Doyle-Cooper C., Hudson K.E., Cooper A.B., Ota T., Skog P., Dawson P.E., Zwick M.B., Schief W.R., Burton D.R., Nemazee D. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10. J Immunol 2013, 191:3186-3191. PubMed PMID: 23940276; PubMed Central PMCID: PMC3773228. 10.4049/jimmunol.1301285.
28. Moldt B., Rakasz E.G., Schultz N., Chan-Hui P.Y., Swiderek K., Weisgrau K.L., Piaskowski S.M., Bergman Z., Watkins D.I., Poignard P., Burton D.R. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proc Natl Acad Sci U S A 2012, 109:18921-18925. PubMed PMID: 23100539; PubMed Central PMCID: PMC3503218. 10.1073/pnas.1214785109.
29. Hammer S.M., Sobieszczyk M.E., Janes H., Karuna S.T., Mulligan M.J., Grove D., Koblin B.A., Buchbinder S.P., Keefer M.C., Tomaras G.D., Frahm N., Hural J., Anude C., Graham B.S., Enama M.E., Adams E., DeJesus E., Novak R.M., Frank I., Bentley C., Ramirez S., Fu R., Koup R.A., Mascola J.R., Nabel G.J., Montefiori D.C., Kublin J., McElrath M.J., Corey L., Gilbert P.B., Team H.S. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med 2013, 369:2083-2092. PubMed PMID: 24099601; PubMed Central PMCID: PMC4030634. 10.1056/NEJMoa1310566.
30. Barouch D.H., Stephenson K.E., Borducchi E.N., Smith K., Stanley K., McNally A.G., Liu J., Abbink P., Maxfield L.F., Seaman M.S., Dugast A.S., Alter G., Ferguson M., Li W., Earl P.L., Moss B., Giorgi E.E., Szinger J.J., Eller L.A., Billings E.A., Rao M., Tovanabutra S., Sanders-Buell E., Weijtens M., Pau M.G., Schuitemaker H., Robb M.L., Kim J.H., Korber B.T., Michael N.L. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell 2013, 155(3):531-539. PubMed PMID: 24243013; PubMed Central PMCID: PMC3846288. 10.1016/j.cell.2013.09.061.
31. Borthwick N., Ahmed T., Ondondo B., Hayes P., Rose A., Ebrahimsa U., Hayton E.J., Black A., Bridgeman A., Rosario M., Hill A.V., Berrie E., Moyle S., Frahm N., Cox J., Colloca S., Nicosia A., Gilmour J., McMichael A.J., Dorrell L., Hanke T. Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1. Mol Therapy 2014, 22:464-475. PubMed PMID: 24166483; PubMed Central PMCID: PMC3911893. 10.1038/mt.2013.248.
32. Barouch D.H., Liu J., Peter L., Abbink P., Iampietro M.J., Cheung A., Alter G., Chung A., Dugast A.S., Frahm N., McElrath M.J., Wenschuh H., Reimer U., Seaman M.S., Pau M.G., Weijtens M., Goudsmit J., Walsh S.R., Dolin R., Baden L.R. Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J Infect Dis 2013, 207:248-256. PubMed PMID: 23125443; PubMed Central PMCID: PMC3532832. 10.1093/infdis/jis671.
33. Barouch D.H., Picker L.J. Novel vaccine vectors for HIV-1. Nat Rev Microbiol 2014, 12:765-771. PubMed PMID: 25296195; PubMed Central PMCID: PMC4237164. 10.1038/nrmicro3360.
34. Fischer W., Perkins S., Theiler J., Bhattacharya T., Yusim K., Funkhouser R., Kuiken C., Haynes B., Letvin N.L., Walker B.D., Hahn B.H., Korber B.T. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 2007, 13:100-106. PubMed PMID: 17187074. 10.1038/nm1461.
35. Korber B.T., Letvin N.L., Haynes B.F. T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces. J Virol 2009, 83:8300-8314. PubMed PMID: 19439471; PubMed Central PMCID: PMC2738160. 10.1128/JVI.00114-09.
36. Hulot S.L., Korber B., Giorgi E.E., Vandergrift N., Saunders K.O., Balachandran H., Mach L.V., Lifton M.A., Pantaleo G., Tartaglia J., Phogat S., Jacobs B., Kibler K., Perdiguero B., Gomez C.E., Esteban M., Rosati M., Felber B.K., Pavlakis G.N., Parks R., Lloyd K., Sutherland L., Scearce R., Letvin N.L., Seaman M.S., Alam S.M., Montefiori D., Liao H.X., Haynes B.F., Santra S. Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus and trivalent mosaic Envelope vaccines formulated as a DNA prime, NYVAC and Envelope protein boost. J Virol 2015, PubMed PMID: 25855741. 10.1128/JVI. 00383-15.
37. Letourneau S., Im E.J., Mashishi T., Brereton C., Bridgeman A., Yang H., Dorrell L., Dong T., Korber B., McMichael A.J., Hanke T. Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS One 2007, 2:e984. PubMed PMID: 17912361; PubMed Central PMCID: PMC1991584. 10.1371/journal.pone.0000984.
38. Kulkarni V., Valentin A., Rosati M., Alicea C., Singh A.K., Jalah R., Broderick K.E., Sardesai N.Y., Le Gall S., Mothe B., Brander C., Rolland M., Mullins J.I., Pavlakis G.N., Felber B.K. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS One 2014, 9:e86254. PubMed PMID: 24465991; PubMed Central PMCID: PMC3900501. 10.1371/journal.pone.0086254.
39. Mothe B., Hu X., Llano A., Rosati M., Olvera A., Kulkarni V., Valentin A., Alicea C., Pilkington G.R., Sardesai N.Y., Rocafort M., Crespo M., Carrillo J., Marco A., Mullins J.I., Dorrell L., Hanke T., Clotet B., Pavlakis G.N., Felber B.K., Brander C. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques. J Transl Med 2015, 13:60. PubMed PMID: 25879820; PubMed Central PMCID: PMC4336696. 10.1186/s12967-015-0392-5.
40. Locci M., Havenar-Daughton C., Landais E., Wu J., Kroenke M.A., Arlehamn C.L., Su L.F., Cubas R., Davis M.M., Sette A., Haddad E.K., International AVIPCPI, Poignard P., Crotty S. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013, 39:758-769. PubMed PMID: 24035365; PubMed Central PMCID: PMC3996844. 10.1016/j.immuni.2013.08.031.
41. Canoso R.T., Zon L.I., Groopman J.E. Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987, 65:495-498. PubMed PMID: 3580308.
42. Morrow W.J., Isenberg D.A., Sobol R.E., Stricker R.B., Kieber-Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 1991, 58:163-180. PubMed PMID: 1985795.
43. Barouch D.H., Michael N.L. Accelerating HIV-1 vaccine efficacy trials. Cell 2014, 159:969-972. PubMed PMID: 25416935; PubMed Central PMCID: PMC4246198. 10.1016/j.cell.2014.10.046.
44. Haynes B.F., Verkoczy L. AIDS/HIV Host controls of HIV neutralizing antibodies. Science 2014, 344:588-589. PubMed PMID: 24812389; PubMed Central PMCID: PMC4162091. 10.1126/science.1254990.
45. Haynes B.F., Kelsoe G., Harrison S.C., Kepler T.B. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol 2012, 30:423-433. PubMed PMID: 22565972; PubMed Central PMCID: PMC3512202. 10.1038/nbt.2197.
46. Liao H.X., Lynch R., Zhou T., Gao F., Alam S.M., Boyd S.D., Fire A.Z., Roskin K.M., Schramm C.A., Zhang Z., Zhu J., Shapiro L., Program N.C.S., Mullikin J.C., Gnanakaran S., Hraber P., Wiehe K., Kelsoe G., Yang G., Xia S.M., Montefiori D.C., Parks R., Lloyd K.E., Scearce R.M., Soderberg K.A., Cohen M., Kamanga G., Louder M.K., Tran L.M., Chen Y., Cai F., Chen S., Moquin S., Du X., Joyce M.G., Srivatsan S., Zhang B., Zheng A., Shaw G.M., Hahn B.H., Kepler T.B., Korber B.T., Kwong P.D., Mascola J.R., Haynes B.F. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 2013, 496:469-476. PubMed PMID: 23552890; PubMed Central PMCID: PMC3637846. 10.1038/nature12053.
47. Doria-Rose N.A., Schramm C.A., Gorman J., Moore P.L., Bhiman J.N., DeKosky B.J., Ernandes M.J., Georgiev I.S., Kim H.J., Pancera M., Staupe R.P., Altae-Tran H.R., Bailer R.T., Crooks E.T., Cupo A., Druz A., Garrett N.J., Hoi K.H., Kong R., Louder M.K., Longo N.S., McKee K., Nonyane M., O'Dell S., Roark R.S., Rudicell R.S., Schmidt S.D., Sheward D.J., Soto C., Wibmer C.K., Yang Y., Zhang Z., Program N.C.S., Mullikin J.C., Binley J.M., Sanders R.W., Wilson I.A., Moore J.P., Ward A.B., Georgiou G., Williamson C., Abdool Karim S.S., Morris L., Kwong P.D., Shapiro L., Mascola J.R. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 2014, 509:55-62. PubMed PMID: 24590074; PubMed Central PMCID: PMC4395007. 10.1038/nature13036.
48. Moore P.L., Gray E.S., Wibmer C.K., Bhiman J.N., Nonyane M., Sheward D.J., Hermanus T., Bajimaya S., Tumba N.L., Abrahams M.R., Lambson B.E., Ranchobe N., Ping L., Ngandu N., Abdool Karim Q., Abdool Karim S.S., Swanstrom R.I., Seaman M.S., Williamson C., Morris L. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med 2012, 18:1688-1692. PubMed PMID: 23086475; PubMed Central PMCID: PMC3494733. 10.1038/nm.2985.
49. Wibmer C.K., Bhiman J.N., Gray E.S., Tumba N., Abdool Karim S.S., Williamson C., Morris L., Moore P.L. Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. PLoS Pathogens 2013, 9:e1003738. PubMed PMID: 24204277; PubMed Central PMCID: PMC3814426. 10.1371/journal.ppat.1003738.
50. Gao F., Bonsignori M., Liao H.X., Kumar A., Xia S.M., Lu X., Cai F., Hwang K.K., Song H., Zhou T., Lynch R.M., Alam S.M., Moody M.A., Ferrari G., Berrong M., Kelsoe G., Shaw G.M., Hahn B.H., Montefiori D.C., Kamanga G., Cohen M.S., Hraber P., Kwong P.D., Korber B.T., Mascola J.R., Kepler T.B., Haynes B.F. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell 2014, 158:481-491. PubMed PMID: 25065977; PubMed Central PMCID: PMC4150607. 10.1016/j.cell.2014.06.022.
51. Lyumkis D., Julien J.P., de Val N., Cupo A., Potter C.S., Klasse P.J., Burton D.R., Sanders R.W., Moore J.P., Carragher B., Wilson I.A., Ward A.B. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 2013, 342:1484-1490. PubMed PMID: 24179160; PubMed Central PMCID: PMC3954647. 10.1126/science.1245627.
52. Julien J.P., Cupo A., Sok D., Stanfield R.L., Lyumkis D., Deller M.C., Klasse P.J., Burton D.R., Sanders R.W., Moore J.P., Ward A.B., Wilson I.A. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 2013, 342:1477-1483. PubMed PMID: 24179159; PubMed Central PMCID: PMC3886632. 10.1126/science.1245625.
53. Mao Y., Wang L., Gu C., Herschhorn A., Desormeaux A., Finzi A., Xiang S.H., Sodroski J.G. Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A 2013, 110:12438-12443. PubMed PMID:;1; 23757493; PubMed Central PMCID: PMC3725050. 10.1073/pnas.1307382110.
54. Bartesaghi A., Merk A., Borgnia M.J., Milne J.L., Subramaniam S. Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat Struct Mol Biol 2013, 20:1352-1357. PubMed PMID:;1; 24154805; PubMed Central PMCID: PMC3917492. 10.1038/nsmb.2711.
55. Pancera M., Zhou T., Druz A., Georgiev I.S., Soto C., Gorman J., Huang J., Acharya P., Chuang G.Y., Ofek G., Stewart-Jones G.B., Stuckey J., Bailer R.T., Joyce M.G., Louder M.K., Tumba N., Yang Y., Zhang B., Cohen M.S., Haynes B.F., Mascola J.R., Morris L., Munro J.B., Blanchard S.C., Mothes W., Connors M., Kwong P.D. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 2014, 514:455-461. PubMed PMID:;1; 25296255; PubMed Central PMCID: PMC4348022. 10.1038/nature13808.
56. Sharma S.K., de Val N., Bale S., Guenaga J., Tran K., Feng Y., Dubrovskaya V., Ward A.B., Wyatt R.T. Cleavage-Independent HIV-1 Env Trimers engineered as soluble native spike mimetics for vaccine design. Cell Reports 2015, PubMed PMID:25892233. 10.1016/j.celrep.2015.03.047.
57. Kang Y.K., Andjelic S., Binley J.M., Crooks E.T., Franti M., Iyer S.P., Donovan G.P., Dey A.K., Zhu P., Roux K.H., Durso R.J., Parsons T.F., Maddon P.J., Moore J.P., Olson W.C. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine 2009, 27:5120-5132. PubMed PMID:;1; 19567243; PubMed Central PMCID: PMC4340663. 10.1016/j.vaccine.2009.06.037.
58. Tong T., Crooks E.T., Osawa K., Robinson J.E., Barnes M., Apetrei C., Binley J.M. Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques. Virology 2014, 456-457:55-69. PubMed PMID: 24882891; PubMed Central PMCID: PMC4037872. 10.1016/j.virol.2014.03.015.
59. Navis M., Tran K., Bale S., Phad G.E., Guenaga J., Wilson R., Soldemo M., McKee K., Sundling C., Mascola J., Li Y., Wyatt R.T., Karlsson Hedestam G.B. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization. PLoS Pathogens 2014, 10:e1004337. PubMed PMID: 25166308; PubMed Central PMCID: PMC4148451. 10.1371/journal.ppat.1004337.
60. Jardine J., Julien J.P., Menis S., Ota T., Kalyuzhniy O., McGuire A., Sok D., Huang P.S., MacPherson S., Jones M., Nieusma T., Mathison J., Baker D., Ward A.B., Burton D.R., Stamatatos L., Nemazee D., Wilson I.A., Schief W.R. Rational HIV immunogen design to target specific germline B cell receptors. Science 2013, 340:711-716. PubMed PMID: 23539181; PubMed Central PMCID: PMC3689846. 10.1126/science.1234150.
61. McGuire A.T., Dreyer A.M., Carbonetti S., Lippy A., Glenn J., Scheid J.F., Mouquet H., Stamatatos L. HIV antibodies Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies. Science 2014, 346:1380-1383. PubMed PMID: 25504724; PubMed Central PMCID: PMC4290850. 10.1126/science.1259206.
62. McGuire A.T., Hoot S., Dreyer A.M., Lippy A., Stuart A., Cohen K.W., Jardine J., Menis S., Scheid J.F., West A.P., Schief W.R., Stamatatos L., Engineering H.I.V. envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J Exp Med 2013, 210:655-663. PubMed PMID: 23530120; PubMed Central PMCID: PMC3620356. 10.1084/jem.20122824.
63. Aussedat B., Vohra Y., Park P.K., Fernandez-Tejada A., Alam S.M., Dennison S.M., Jaeger F.H., Anasti K., Stewart S., Blinn J.H., Liao H.X., Sodroski J.G., Haynes B.F., Danishefsky S.J. Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines. J Am Chem Soc 2013, 135:13113-13120. PubMed PMID: 23915436; PubMed Central PMCID: PMC3826081. 10.1021/ja405990z.
64. Alam S.M., Dennison S.M., Aussedat B., Vohra Y., Park P.K., Fernandez-Tejada A., Stewart S., Jaeger F.H., Anasti K., Blinn J.H., Kepler T.B., Bonsignori M., Liao H.X., Sodroski J.G., Danishefsky S.J., Haynes B.F. Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors. Proc Natl Acad Sci U S A 2013, 110:18214-18219. PubMed PMID: 24145434; PubMed Central PMCID: PMC3831483. 10.1073/pnas.1317855110.
65. Ma B.J., Alam S.M., Go E.P., Lu X., Desaire H., Tomaras G.D., Bowman C., Sutherland L.L., Scearce R.M., Santra S., Letvin N.L., Kepler T.B., Liao H.X., Haynes B.F. Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathogens 2011, 7:e1002200. PubMed PMID: 21909262; PubMed Central PMCID: PMC3164629. 10.1371/journal.ppat.1002200.
66. Alam S.M., Liao H.X., Dennison S.M., Jaeger F., Parks R., Anasti K., Foulger A., Donathan M., Lucas J., Verkoczy L., Nicely N., Tomaras G.D., Kelsoe G., Chen B., Kepler T.B., Haynes B.F. Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation. J Virol 2011, 85:11725-11731. PubMed PMID: 21917975; PubMed Central PMCID: PMC3209283. 10.1128/JVI. 05680-11.
67. Dennison S.M., Sutherland L.L., Jaeger F.H., Anasti K.M., Parks R., Stewart S., Bowman C., Xia S.M., Zhang R., Shen X., Scearce R.M., Ofek G., Yang Y., Kwong P.D., Santra S., Liao H.X., Tomaras G., Letvin N.L., Chen B., Alam S.M., Haynes B.F. Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41. PLoS One 2011, 6:e27824. PubMed PMID: 22140469; PubMed Central PMCID: PMC3227606. 10.1371/journal.pone.0027824.